Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial cell envelope phospholipids and phosphate-containing components represent a diverse class of essential structural and functional molecules that define the boundary of the bacterial cell (NIH, Medical Microbiology). These include anionic phospholipids like phosphatidylglycerol and cardiolipin in the plasma membrane, as well as surface-exposed polymers such as lipopolysaccharides (LPS) in Gram-negative bacteria and teichoic acids in Gram-positive bacteria (Biology Ease). These components are vital for maintaining membrane integrity, regulating ion homeostasis, and anchoring proteins involved in cell wall synthesis and division (PMC, Progress in Lipid Research). Because bacterial membranes are significantly more anionic than the zwitterionic membranes of mammalian cells, they serve as selective targets for several classes of antibiotics, including polymyxins and lipopeptides like daptomycin (PubMed). Drugs interacting with these targets typically cause rapid membrane depolarization or physical disruption, leading to the leakage of intracellular contents and cell death, which is particularly valuable for treating multidrug-resistant infections (PMC, Journal of Biological Chemistry).
Drugs targeting these components typically act by binding to anionic headgroups of phospholipids or phosphate moieties in lipopolysaccharides and teichoic acids, leading to membrane permeabilization, pore formation, or inhibition of cell wall synthesis precursors like Lipid II.
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell envelope phospholipids and phosphate-containing components.